What you'll learn

  • Identify classical and novel psychedelic agents

  • Define what is meant by psychedelic-assisted psychotherapy (PAP)

  • Describe models of psychotherapy that may support PAP

  • Outline principles of harm reduction and a trauma-informed approach to PAP

  • View course registration page for additional learning objectives

Course description

This course will address the research on the benefits of psychedelics for treating mental health disorders. It will explore the critical issues that clinicians must recognize and address to provide competent, safe and trauma-informed PAP. Finally, it will introduce trainings and organizations that promote effective and ethical work. We are pleased to provide options for both in-person and virtual attendance. Join colleagues from around the world to advance your knowledge and confidence in this burgeoning field!

This is an accredited course offered by Cambridge Health Allianace. This course is targeted to Primary Care Physicians, Specialty Physicians, Psychologists, Social Workers and Counselors. This course may also be of interest to physicians who practice in Family Medicine, Internal Medicine, Lifestyle and Mind-Body Medicine, Psychiatry and Neurology, Psychology and Mental Health. 

*Register before January 12, 2023 to receive the discounted price. 

Contact ceprograms@hms.harvard.edu with questions.

You may also like


Learn about the opioid epidemic in the United States, including information about treatment and recovery from opioid addiction.

Registration Deadline
Available now

Understand the principles governing how drugs impact the body, and see how these concepts apply to the treatment and prevention of disease.

Registration Deadline